NIH Issues Contract Notice for Automated Equipment to Support COVID-19 Research

The National Institutes of Health (NIH), through the National Center for Advancing Translational Sciences (NCATS), has issued a contract notice for the procurement of an automated multi-mode reagent dispenser to support research into COVID-19 and the development of new treatments for rare diseases. The contract, Solicitation No: 75N95021Q00151, aims to acquire equipment that can integrate with existing equipment to streamline high-throughput screening processes. This is critical for the Antiviral Program for Pandemics Project, which seeks to develop next-generation antivirals and treatments for rare diseases.

Key Takeaways:

• The NIH's Therapeutic Development Branch (TBD) within the National Center for Advancing Translational Sciences (NCATS) requires an automated multi-mode reagent dispenser for the Antiviral Program for Pandemics Project.
• The project aims to develop assays for predictive toxicity of antisense oligonucleotides (ASOs), which will be used as the next generation of antivirals and treatments for rare diseases.
• Automated equipment will be integrated to streamline the process for high-throughput screening of neuronal spheroid assays to assess predictive neurotoxicity.
• The NAICS code number for this requirement is 334516.
• The contract notice was posted on August 25, 2021, and the response date is September 16, 2021.

Statistics:

• The contract notice is Solicitation No: 75N95021Q00151.
• The posting date for the contract notice is August 25, 2021.
• The response date for the contract notice is September 16, 2021.
• The NAICS code number for this requirement is 334516.

Sources:

• [Source] WASHINGTON: HEALTH AND HUMAN SERVICES, DEPARTMENT OF".
• Contract notice, Solicitation No: 75N95021Q00151, posted on August 25, 2021.